1. Manjunatha N, Ram D. Panic disorder in general medical practice- A narrative review. J Family Med Prim Care. 2022 Mar;11(3):861-869. doi: 10.4103/jfmpc.jfmpc_888_21.
2. Guaiana G, Meader N, Barbui C, Davies SJ, Furukawa TA, Imai H, Dias S, Caldwell DM, Koesters M, Tajika A, Bighelli I, Pompoli A, Cipriani A, Dawson S, Robertson L. Pharmacological treatments in panic disorder in adults: a network meta-analysis. Cochrane Database Syst Rev. 2023 Nov 28;11(11):CD012729. doi: 10.1002/14651858.CD012729.pub3.
3. Kim YK. Panic Disorder: Current Research and Management Approaches. Psychiatry Investig. 2019 Jan;16(1):1-3. doi: 10.30773/pi.2019.01.08.
4. Penninx BWJH, Pine DS, Holmes EA, Reif A. Benzodiazepines for the long-term treatment of anxiety disorders? - Authors' reply. Lancet. 2021 Jul 10;398(10295):120. doi: 10.1016/S0140-6736(21)00931-4.
5. Edinoff AN, Nix CA, Hollier J, Sagrera CE, Delacroix BM, Abubakar T, Cornett EM, Kaye AM, Kaye AD. Benzodiazepines: Uses, Dangers, and Clinical Considerations. Neurol Int. 2021 Nov 10;13(4):594-607. doi: 10.3390/neurolint13040059.
6. Nardi AE, et al. A randomized, naturalistic, parallel-group study for the long-term treatment of panic disorder with clonazepam or paroxetine. J Clin Psychopharmacol. 2012 Feb;32(1):120-6. doi: 10.1097/JCP.0b013e31823fe4bd.
7. Ziffra M. Panic disorder: A review of treatment options. Ann Clin Psychiatry. 2021 May;33(2):124-133. doi: 10.127788/acp.0014.
8. Melaragno AJ. Pharmacotherapy for Anxiety Disorders: From First-Line Options to Treatment Resistance. Focus (Am Psychiatr Publ). 2021 Jun;19(2):145-160. doi: 10.1176/appi.focus.20200048. Epub 2021 Jun 17.
9. Sub Laban T, Saadabadi A. Monoamine Oxidase Inhibitors (MAOI). In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK539848/
10. Garakani A, Freire RC, Buono FD, Thom RP, Larkin K, Funaro MC, Salehi M, Perez-Rodriguez MM. An umbrella review on the use of antipsychotics in anxiety disorders: A registered report protocol. PLoS One. 2022 Jun 16;17(6):e0269772. doi: 10.1371/journal.pone.0269772.
11. Masdrakis VG, Baldwin DS. Anticonvulsant and antipsychotic medications in the pharmacotherapy of panic disorder: a structured review. Ther Adv Psychopharmacol. 2021 Mar 21;11:20451253211002320. doi: 10.1177/20451253211002320.
12. Pompoli A, Furukawa TA, Efthimiou O, Imai H, Tajika A, Salanti G. Dismantling cognitive-behaviour therapy for panic disorder: a systematic review and component network meta-analysis. Psychol Med. 2018 Sep;48(12):1945-1953. doi: 10.1017/S0033291717003919.
13. Cackovic C, Nazir S, Marwaha R. Panic Disorder. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK430973/
14. Tremblay MA, Denis I, Turcotte S, DeGrâce M, Tully PJ, Foldes-Busque G. Cognitive-Behavioral Therapy for Panic Disorder in Patients with Stable Coronary Artery Disease: A Feasibility Study. J Clin Psychol Med Settings. 2023 Mar;30(1):28-42. doi: 10.1007/s10880-022-09876-7.
15. Bighelli I, Castellazzi M, Cipriani A, Girlanda F, Guaiana G, Koesters M, Turrini G, Furukawa TA, Barbui C. Antidepressants versus placebo for panic disorder in adults. Cochrane Database Syst Rev. 2018 Apr 5;4(4):CD010676. doi: 10.1002/14651858.CD010676.pub2.
16. Goddard AW, Mahmud W, Medlock C, Shin YW, Shekhar A. A controlled trial of quetiapine XR coadministration treatment of SSRI-resistant panic disorder. Ann Gen Psychiatry. 2015 Sep 15;14:26. doi: 10.1186/s12991-015-0064-0.
17. Perna G, Alessandra A, Raffaele B, Elisa M, Giuseppina D, Paolo C, Maria N, Daniela C. Is There Room for Second-Generation Antipsychotics in the Pharmacotherapy of Panic Disorder? A Systematic Review Based on PRISMA Guidelines. Int J Mol Sci. 2016 Apr 13;17(4):551. doi: 10.3390/ijms17040551.
Facebook 
Masuk dengan Email
